insights_auto
Outlook: 44.1% bullish·5.1% bearish
Go to analysischevron_right
PFE:NYSE
Pfizer Inc
$27.41
arrow_downward
-1.40%(-0.39) 1D
$27.41
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 5, 4:03:15 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PFE...
Open
$27.65
High
$27.72
Low
$27.12
Mkt. cap
156.23B
Avg. vol.
32.96M
Volume
32.35M
Dividend
6.28%
Quarterly dividend
$0.43
Ex-dividend date
Jul 24, 2026
P/E ratio
36.29
52-wk high
$29.21
52-wk low
$23.62
EPS
$0.76
Beta
0.32
Shares outstanding
5.70B
No. of employees
75K
Open
$27.65
High
$27.72
Low
$27.12
Mkt. cap
156.23B
Avg. vol.
32.96M
Volume
32.35M
Dividend
6.28%
Quarterly dividend
$0.43
Ex-dividend date
Jul 24, 2026
P/E ratio
36.29
52-wk high
$29.21
52-wk low
$23.62
EPS
$0.76
Beta
0.32
Shares outstanding
5.70B
No. of employees
75K
News stories
From web sources and news partners
Yahoo Finance
·
46 minutes ago
Why Pfizer Might Be the Most Underrated Dividend Stock to Buy Right Now
Benzinga
·
1 hour ago
Florida Attorney General Sues Pfizer for 'Misleading' COVID-19 Vaccine Safety Claims
Kalkine Media
·
2 hours ago
Why is Pfizer (NYSE:PFE) stock in focus as new immunology trial data lands?
News Corp
·
3 hours ago
Vaxcyte Stock Spikes 27% as Lead Vaccine Candidate Takes Aim at Pfizer and Merck
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer Inc
CEOAlbert Bourla
Employees75K
Founded1849
HeadquartersNew York, New York, United States
SectorPharmaceutical industry
Websitepfizer.com